OncoImmunity is a bioinformatics company offering proprietary machine-learning based software to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity is dedicated to develop software solutions that facilitate effective patient selection for cancer immunotherapy, and identify optimal neoantigen targets for truly personalised cancer vaccines & cell therapies in clinically actionable time-frame.
Caprion Biosciences provides biomarker and immune-monitoring know-how to the life science industry. Our services include cutting-edge multiplexed flow cytometry, robust quantitative mass spectrometry workflows, and unmatched identification and characterization of tumor antigens/neo-epitopes. We’re committed to advancing your drug development programs with tailored study designs, and best-in-class sample management and bioinformatics.
Personalis, Inc. provides genomic solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Our patented ACE Technology improves every step in the sequencing process, from nucleic acid extraction…Read More
Almac has been supplying peptides to the research community and for clinical trials for over 20 years. The field of personalized cancer vaccines requires a new manufacturing paradigm to ensure high throughput manufacture of multiple neoantigens in an appropriate timescale to the required quality and regulatory standards. Almac has created a unique offering to meet all of those demands, which can be tailored to meet specific client needs.
Bachem provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. The group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership. Bachem. Pioneering Partner for Peptides.
JPT Peptide Technologies is a leading provider and quality leader for innovative peptide-based services and products in all development phases of immunotherapies. Our proprietary technologies cover cost effective antigen and neo-epitope discovery and qualification, cellular and humoral immune response monitoring and various therapeutic applications. All production and services are regulated according to ISO 9001:2015 guidelines. Read More
At Provepharm Life Solutions, we have been supplying peptide-based vaccines for more than 15 years, either as APIs or as drug products. The field of Personalized Peptide Vaccines requires GMP peptide manufacturers to have strong expertise in immunopeptides as well as the ability to invest in dedicated production units to meet PPV clinical trial specifics. Our company tackles all these PPV requirements including delivering in a timely manner new peptide sequences needed for each patient vaccine. Read more.